![June Bray](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
June Bray
Directeur/Membre du Conseil chez
BIOXCEL THERAPEUTICS, INC.
Fortune : - $ au 31/08/2026
Profil
June Bray joined Quince’s Board of Directors in June 2022.
Ms. Bray possesses more than forty years of extensive U.S.
and global regulatory experience in the healthcare industry and a proven track record of successful regulatory interactions with health authorities which have led to the approval of 32 NDAs in the U.S.
and multiple international approvals.
She most recently served as Senior Vice President, Global Regulatory Affairs and Medical Writing at Allergan, where she was responsible for regulatory strategies on development projects and lifecycle management in all therapeutic areas, including psychiatry and neurology.
During her tenure, she led numerous NDA approvals, including Namenda XR®, Namzaric®, Vraylar®, and Ubrelvy®.
Previously, Ms. Bray served as Vice President, Regulatory Affairs at Organon (now Merck), where she led regulatory activities for development and marketed products, including the NDA for Saprhis® (asenapine) for the treatment of schizophrenia and bipolar disorder.
Earlier in her career, Ms. Bray held numerous roles of increasing responsibility over a 25-year period at Berlex Laboratories, Inc. (now Bayer HealthCare Pharmaceuticals).
She began her pharmaceutical career in sterile manufacturing at Hoechst-Roussel Pharmaceuticals (now Sanofi-Aventis).
Ms. Bray holds a B.S.
in Pharmacy from the University of Rhode Island and an M.B.A in Pharmaceutical Marketing from Fairleigh Dickinson University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 02/01/2026 | 0 ( -.--% ) | - $ | 31/08/2026 | |
| 09/01/2026 | 0 ( -.--% ) | - $ | 31/08/2026 |
Postes actifs de June Bray
| Sociétés | Poste | Début |
|---|---|---|
| BIOXCEL THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/03/2021 |
| QUINCE THERAPEUTICS, INC. | Directeur/Membre du Conseil | 22/04/2026 |
Anciens postes connus de June Bray
| Sociétés | Poste | Fin |
|---|---|---|
| QUINCE THERAPEUTICS, INC. | Directeur/Membre du Conseil | 30/01/2026 |
Travecta Therapeutics Pte Ltd.
 Travecta Therapeutics Pte Ltd. Packaged SoftwareTechnology Services Develops a novel chemistry platform for delivery of therapies to the brain | Directeur/Membre du Conseil | 01/10/2022 |
| ALLERGAN, INC. | Conseiller Juridique Général | 01/01/2020 |
| ORGANON & CO. | Conseiller Juridique Général | 01/01/2008 |
Berlex Laboratories, Inc. | Conseiller Juridique Général | 01/01/2006 |
Formation de June Bray
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
75
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Allergan, Inc.
 Allergan, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
University of Rhode Island
 University of Rhode Island Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fairleigh Dickinson University
 Fairleigh Dickinson University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Allergan Ltd. (Ireland)
 Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes pharmaceuticals, devices, biological, surgical & regenerative medicine products | Health Technology |
Berlex Laboratories, Inc. | Health Technology |
Quince Therapeutics, Inc.
 Quince Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops drugs for the treatment of central nervous system disorders and Alzheimer’s diseases | Health Technology |
BioXcel Therapeutics, Inc.
 BioXcel Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops transformative medicines in neuroscience and immuno-oncology | Health Technology |
Travecta Therapeutics Pte Ltd.
Travecta Therapeutics Pte Ltd. Packaged SoftwareTechnology Services Develops a novel chemistry platform for delivery of therapies to the brain | Technology Services |
Organon & Co.
 Organon & Co. Pharmaceuticals: MajorHealth Technology Develops and delivers women health, trusted legacy brands and therapeutics | Health Technology |
